Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2005
06/15/2005CN1206535C Modulating multiple lineage kinase proteins
06/15/2005CN1206242C Anti-angiogenesis and anti-cancer function of angiogenin combined with nucleotide
06/15/2005CN1206230C 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
06/15/2005CN1206228C N-heterocyclic derivatives as NOS inhibitors
06/15/2005CN1206221C Acridine derivatives
06/15/2005CN1206219C N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/15/2005CN1206213C N-arylsulfonyl amino acid omega amides
06/15/2005CN1205984C Medicine composition with synergrstic action and preparation process and use thereof
06/15/2005CN1205983C Method for making capsule for promoting promoting blood-circulation and relieving pain
06/15/2005CN1205969C Ointment of Chinese traditional medicine for curing fever and cough
06/15/2005CN1205959C Plaster for treating arthritis and cervical vertebra and vertebra lumbalis diseases
06/14/2005US6906203 Anticancer agents; such as 2-Amino-3-cyano-4-(2-bromo-4,5-dimethoxyphenyl)-4H-indolo(4,5-b)pyran
06/14/2005US6906196 Antiinflammatory agents, rheumatic disorders
06/14/2005US6906193 N-type calcium channel antagonists for the treatment of pain
06/14/2005US6906170 Anti-inflammatory peptides derived from IL-2 and analogues thereof
06/14/2005US6906094 1,2,4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase
06/14/2005US6906085 Tetrahydropyran derivatives as neurokinin receptor antagonists
06/14/2005US6906084 Indole derivatives as factor Xa inhibitors
06/14/2005US6906080 Antiinflammatory agents, analgesics, drug abuse, alcoholism
06/14/2005US6906074 A tachykinin antagonist for used as antiinflammatory agent, antiallergic agent, analgesic, antiemetics, treating irritable colon syndrome, skin disorders
06/14/2005US6906066 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/14/2005US6906065 4-Amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhibitors of cell-cycle kinases
06/14/2005US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents
06/14/2005US6906041 Treatment of immune diseases
06/14/2005US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases
06/14/2005US6905685 Antiproliferative agents; monoclonal antibodies; blocking immunology response; autoimmune disease, antidiabetic agents, antiarthritic agents, antitumor, anticancer agents
06/14/2005US6905676 Cytokines; anttumor agents; viricides; bactericides; antiinflammatory agents
06/14/2005CA2420576C Immunoregulatory compounds, derivatives thereof and their use
06/14/2005CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
06/14/2005CA2274591C Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them
06/14/2005CA2234096C 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
06/14/2005CA2155323C Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
06/14/2005CA2150229C Nitric esters having a pharmacological activity and process for their preparation
06/14/2005CA2086908C Substituted n-phenyl-2-cyano-3-hydroxy-enamides
06/09/2005WO2005051969A1 Novel analgesic compounds, extracts containing same and methods of preparation
06/09/2005WO2005051912A1 Piperidine compound and method for producing same
06/09/2005WO2005051425A1 Procaspase 1 activation inhibitor
06/09/2005WO2005030787A3 Oligonucleotide compositions and methods for treating disease including inflammatory conditions
06/09/2005WO2005000344A3 Method for identification of tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof
06/09/2005WO2004052845A8 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
06/09/2005US20050124796 Mouse cytokine receptor
06/09/2005US20050124795 DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor
06/09/2005US20050124696 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance
06/09/2005US20050124691 Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
06/09/2005US20050124689 Tocopherol enriched compositions and amelioration of inflammatory symptoms
06/09/2005US20050124672 Antineoplastic agents, analgesics, antipyretics; prostaglandin E2 receptor antagonists; 3-Methyl-4-[6-[N-isobutyl-N-(2-thiazolylsulfonyl)amino]indan-5-yloxymethyl]benzoic acid, a C1-4 alkyl ester, or a non-toxic salt
06/09/2005US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity
06/09/2005US20050124665 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance
06/09/2005US20050124654 Compounds and methods of use
06/09/2005US20050124649 Deazapurines and uses thereof
06/09/2005US20050124648 Triazolo-quinolin derivatives useful as adenosine receptor ligands
06/09/2005US20050124647 For example, 4-hydroxy-1,1-di-(5',6'-methylendioxy-indol-2-yl)-butane; antitumor agents, particularly for treating mammary carcinoma and colon carcinoma
06/09/2005US20050124622 Compounds and methods for the treatment of pain
06/09/2005US20050124621 Novel inhibitors of kinases
06/09/2005US20050124617 Agonists to a cannabinoid type 2 receptor; antiinflammatory agents; immunosuppressants; nephritis
06/09/2005US20050124615 3-heteroarly-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b] indole-1-acetamide derivatives, preparation and use thereof in medicaments
06/09/2005US20050124605 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating circulatory, inflammatory, and proliferative disorders
06/09/2005US20050124604 E.g. 1-Benzyl-4-[4-(thiophene-2-carbonyl) piperazin-1-yl]-2-oxo-1,2-dihydro-3-cyano[1,8]-naphthyridine; antinflammatory, -arthritic, -carcinogenic, -tumor, -diabetic agents; septic shock; acute respiratory distress syndrome; casrdiovascular disorders; angiogenesis inhibitors; autoimmune diseases; asthma
06/09/2005US20050124577 8-Azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
06/09/2005US20050124575 Remedies
06/09/2005US20050124574 Purine derivatives
06/09/2005US20050124554 Spermidine derivatives for the treatment of chronic neurodegenerative diseases
06/09/2005US20050124551 Or its cystine-coupled dimer, mixed with a nonsteroidal antiinflammatory agent used to treat contact dermatitis.
06/09/2005US20050124547 Tau-conotoxin peptides
06/09/2005US20050124543 Heterologous polypeptide of the TNF family
06/09/2005US20050124538 for prophylaxis, prevention, treatment or therapy of inflammatory conditions or allergic reactions in a mammal; binds bacterial lipopeptide
06/09/2005US20050124537 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
06/09/2005US20050124050 Osteoclast differentiation inhibitors
06/09/2005US20050124004 Histamine receptor h3 polynucleotides
06/09/2005US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders
06/09/2005US20050123910 Nucleotide sequences coding prolyl oligopeptidase (DPP10) for use in identifying modulator which prevent and treat allergies, asthma, skin and inflammatory diseases
06/09/2005US20050123897 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area; drug delivery kits, patches
06/09/2005US20050123636 Total coumarins include six active compounds, which have been identified as osthal, xanthotoxol xanthotoxin, isopimpinellin, bergapten, imperatorine; little side-effect
06/09/2005US20050123576 Mupirocin compositions for topical use, an improved process of making same and methods of using same
06/09/2005US20050123575 Heating, cooling, reheating and recooling a mixture containing hard fat while stirring; cosmetics, cosmeceutical, pharmaceutical; second temperature is lower than the congelation temperature of the mixture; hard fat is a mixture of triester of glycerin with caprylic, capric and stearic acids
06/09/2005US20050123536 Treatment of immunological disorders using anti-dc30 antibodies
06/09/2005US20050123479 bioassays for screening antiinflammatory agents used for treating or ameliorating the symptoms of T-cell, macrophage or neutrophil mediated diseases in mammals
06/09/2005CA2547467A1 Piperidine compound and method for producing same
06/09/2005CA2547311A1 Novel analgesic compounds, extracts containing same and methods of preparation
06/09/2005CA2547235A1 T-type calcium channel blocker
06/09/2005CA2536188A1 Electrical devices and anti-scarring agents
06/08/2005EP1538207A1 Human antihuman mcp-1 antibody and antibody fragment thereof
06/08/2005EP1537870A2 Methods and compositions for treating cancer
06/08/2005EP1537867A1 Method of photodynamic diagnosis for vascular diseases
06/08/2005EP1537857A1 Mupirocin compositions for topical use, a process of making same and uses thereof
06/08/2005EP1537138A2 Receptors and membrane-associated proteins
06/08/2005EP1537129A1 Akt inhibitors, pharmaceutical compositions, and uses thereof
06/08/2005EP1537112A1 Condensed pyridines and pyrimidines with tie2 (tek) activity
06/08/2005EP1537110A2 Triazospiro compounds having nociceptin receptor affinity
06/08/2005EP1537107A2 Novel processes and intermediates for preparing triazolo-pyridines
06/08/2005EP1537104A1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist
06/08/2005EP1537098A1 Monocyclic derivatives as matrix metalloproteinase inhibitors
06/08/2005EP1537096A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
06/08/2005EP1537090A1 Chromone derivatives as matrix metalloproteinase inhibitors
06/08/2005EP1537086A2 Novel phenanthridines
06/08/2005EP1537084A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of
06/08/2005EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers
06/08/2005EP1537069A2 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE
06/08/2005EP1537067A2 Resolvins: biotemplates for therapeutic interventions
06/08/2005EP1537066A2 Improvements in pharmaceutically useful compounds
1 ... 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 ... 1272